[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fqJ1HC8MIsPVgWaaep_5cNwfSwBDpUgLFaUVyLb0GZxU":3},{"answer":4,"createTime":5,"id":6,"options":7,"origin":13,"question":20,"related":21,"source":32,"type":33},[],"2025-09-23 02:37:30",217763003,[8,9,10,11,12],"饱和水溶液法","研磨法","超声波法","熔融法","冷冻干燥法",{"count":14,"courseId":15,"courseImg":16,"courseName":17,"workId":18,"workName":19},18,"53e1d2ef4961cca8eea3e23969ad2cb9","https:\u002F\u002Ftihai-oss-cloud.itihey.com\u002Fimg\u002F03a579384a6dc297c89809b582fcc767.png","默认课程","work_45264005","第十一章 固体分散体和包合物","下列哪种方法不是环糊精包合物的制备方法?( )",[22,34,44,51,61,71,81,91,101,111],{"answer":23,"createTime":5,"id":24,"options":25,"question":31,"source":32,"type":33},[],217762993,[26,27,28,29,30],"药物在固体分散体中的状态是影响药物溶出速率的重要因素","载体材料提高药物的可润湿性会促进药物溶出","固体分散体是针对易溶性药物所特有的一种制剂技术","药物采用疏水或脂质载体材料制成的固体分散体具有缓释作用","缓释原理是药物的溶出必须首先通过载体材料的网状骨架扩散","下列关于固体分散体速效与缓效原理的叙述错误的是( )","v1",0,{"answer":35,"createTime":5,"id":36,"options":37,"question":43,"source":32,"type":33},[],217762994,[38,39,40,41,42],"固体分散体中的药物都是以分子状态分散在固体载体中的","利用固体分散技术可以制备速释制剂也可以制备缓释制剂","若载体为水溶性,往往可以改善药物的溶出与吸收","聚丙烯酸树脂类材料既可用于制备缓释固体分散体又可制备肠溶性固体分散体","PEG、PVP都是水溶性的固体分散体载体材料","下列关于固体分散技术的叙述错误的是( )",{"answer":45,"createTime":5,"id":46,"options":47,"question":50,"source":32,"type":33},[],217762995,[11,48,49,9,8],"溶剂法","溶剂-熔融法","固体分散体的制备方法错误的是( )",{"answer":52,"createTime":5,"id":53,"options":54,"question":60,"source":32,"type":33},[],217762996,[55,56,57,58,59],"热分析法","X射线衍射法","红外光谱法","薄层色谱法","核磁共振","下列哪项不是固体分散体物相鉴定的方法?( )",{"answer":62,"createTime":5,"id":63,"options":64,"question":70,"source":32,"type":33},[],217762997,[65,66,67,68,69],"分子状态>无定型态>微晶态","分子状态>微晶态>无定型态","无定型态>分子状态>微晶态","无定型态>微晶态>分子状态","微晶态>分子状态>无定型态","固体分散体中药物的溶出速率顺序为( )",{"answer":72,"createTime":5,"id":73,"options":74,"question":80,"source":32,"type":33},[],217762998,[75,76,77,78,79],"乙基纤维素","聚丙烯酸树脂RL","邻苯二甲酸醋酸纤维素","胆固醇","聚维酮","可作为水溶性固体分散体载体材料的是( )",{"answer":82,"createTime":5,"id":83,"options":84,"question":90,"source":32,"type":33},[],217762999,[85,86,87,88,89],"包合物由主分子和客分子两种组分组成","大多数环糊精包合物难以与药物达到等摩尔比包合","制备包合物可以提高药物的生物利用度、降低药物的毒性和刺激性","常见的环糊精有α、β、Y三种,其中β-环糊精最为常用","药物作为客分子经包合后,溶解度增大,稳定性提高","下列关于包合物的叙述错误的是( )",{"answer":92,"createTime":5,"id":93,"options":94,"question":100,"source":32,"type":33},[],217763000,[95,96,97,98,99],"增大药物溶解度","提高药物稳定性","调节释放速率","使药物具有靶向性","掩盖药物的不良气味","下列关于β-CD包合物优点叙述错误的是( )",{"answer":102,"createTime":5,"id":103,"options":104,"question":110,"source":32,"type":33},[],217763001,[105,106,107,108,109],"环糊精是由6~12 个D-葡萄糖分子以1,4-糖苷键连接的环状低聚糖","环糊精为中空圆筒形","孔穴的开口及外部呈疏水性,孔穴的内部呈亲水性","环糊精所形成的包合物通常都是单分子包合物","常用的环糊精有α、β、Y三种,其中最常用的是β环糊精","以下关于环糊精的说法,错误的是( )",{"answer":112,"createTime":5,"id":6,"options":113,"question":20,"source":32,"type":33},[],[8,9,10,11,12]]